Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02951702
Recruitment Status :
First Posted : November 1, 2016
Results First Posted : December 27, 2017
Last Update Posted : December 27, 2017
St. Luke's Hospital, Chesterfield, Missouri
Information provided by (Responsible Party):
Ryan Medas, St. Luke's Hospital, Chesterfield, Missouri